3 ms·
It might be a PR decision to encourage the name to hide the fact Gilead "Profited by Slow-Walking a Promising HIV Therapy". Profit before health. https://www.n
by janice1999 2y ago
It might be a PR decision to encourage the name to hide the fact Gilead "Profited by Slow-Walking a Promising HIV Therapy". Profit before health.
https://www.nytimes.com/2023/07/22/business/gilead-hiv-drug-tenofovir.html https://www.nytimes.com/2023/07/22/business/gilead-hiv-drug-...
- JumpCrisscross 2y ago“For most people, experts say, the two tenofovir-based drugs — the first known as T.D.F., the second called T.A.F. — offer roughly equal risks and benefits.” Do we have an update on the case?
- deleted 2y ago[deleted]